Top 50 Biotechnology Startup Investors in Spain (July 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Centre for the Development of Industrial Technology (CDTI)
VC Fund
|
26 | Spain, United States, France | Grant, Seed | Biotechnology, Health Care, Software | $157k–$16M |
|
Inveready
VC Fund
|
18 | Spain, United States, United Kingdom | Seed, Series A | Software, Biotechnology, Information Technology | $400k–$14M |
|
Criteria Venture Tech
VC Fund
|
15 | Spain, United States, United Kingdom | Seed, Series A | Software, Biotechnology, E-Commerce | $256k–$21M |
|
Clave Capital
VC Fund
|
14 | Spain, Chile, Switzerland | Seed, Series A, Venture - Series Unknown | Biotechnology, Health Care, Software | $462k–$16M |
|
SODENA
VC Fund
|
14 | Spain, United Kingdom | Debt Financing, Seed | Health Care, Biotechnology, Manufacturing | $37k–$922k |
|
Invivo Capital Partners
VC Fund
|
13 | Spain, France, Belgium | Seed, Series A | Biotechnology, Pharmaceutical, Health Care | $1.6M–$70M |
|
ENISA
VC Fund
|
12 | Spain, United States, France | Seed, Debt Financing, Pre-Seed | Software, Health Care, Artificial Intelligence | $66k–$2.1M |
|
Asabys Partners
VC Fund
|
11 | Spain, France, Belgium | Series A, Series B, Seed | Health Care, Biotechnology, Medical Device | $1.2M–$135M |
|
BeAble Capital
VC Fund
|
10 | Spain, Italy | Pre-Seed, Seed | Biotechnology, Manufacturing, Software | $124k–$1.2M |
|
Ysios Capital
VC Fund
|
10 | Spain, United States, Switzerland | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $3.8M–$135M |
|
CDTI Innovación's INNVIERTE program
VC Fund
|
10 | Spain, Panama, Switzerland | Venture - Series Unknown, Seed | Biotechnology, Health Care, Medical | $266k–$16M |
|
Capital Cell
VC Fund
|
10 | Spain, France, United States | Equity Crowdfunding, Seed | Health Care, Biotechnology, Medical | $137k–$1.9M |
|
ICF Capital
VC Fund
|
9 | Spain, United States, Mexico | Debt Financing, Seed | Software, Health Care, Biotechnology | $110k–$6.9M |
|
Alta Life Sciences
VC Fund
|
9 | Spain, United States | Series A, Series B | Biotechnology, Health Care, Medical Device | $3M–$87M |
|
Bullnet Capital
VC Fund
|
8 | Spain, United States, Mexico | Seed, Series A | Software, Information Technology, Manufacturing | $587k–$11M |
|
Xesgalicia
VC Fund
|
7 | Spain, Portugal | Seed, Pre-Seed | Software, Biotechnology, Pharmaceutical | $304k–$5.9M |
|
CRB Inverbío
VC Fund
|
7 | Spain, Italy, Mexico | Series A, Seed | Health Care, Medical, Biotechnology | $2.2M–$8.9M |
|
AdBio partners
VC Fund
|
6 | France, Spain, Belgium | Seed, Series A | Biotechnology, Health Care, Pharmaceutical | $2.2M–$37M |
|
Grow Venture Partners
VC Fund
|
5 | Spain | Seed, Pre-Seed, Venture - Series Unknown | Health Care, Biotechnology, Artificial Intelligence | $106k–$9.5M |
|
Gestion De Capital Riesgo Del Pais Vasco
VC Fund
|
5 | Spain, Ecuador | Seed, Series A | Biotechnology, Health Care, Medical | $213k–$14M |
|
BStartup
VC Fund
|
5 | Spain, Mexico, United States | Seed, Pre-Seed | Software, Information Technology, Artificial Intelligence | $110k–$2.2M |
|
Moira Capital Partners
VC Fund
|
5 | Spain | Private Equity, Venture - Series Unknown | Biotechnology, Apps, Water Purification | $5.5M–$18M |
|
Seed Capital Bizkaia
VC Fund
|
4 | Spain, Mexico, Belgium | Seed, Series A | Software, Biotechnology, Health Care | $119k–$14M |
|
Angels Capital
VC Fund
|
4 | Spain, United States, Ireland | Seed, Angel, Pre-Seed | Software, E-Commerce, Health Care | $104k–$2.5M |
|
Nara Capital
VC Fund
|
4 | Spain | Seed, Venture - Series Unknown, Series A | Life Science, Biotechnology, Medical | $394k–$7.3M |
|
CDTI
VC Fund
|
4 | Spain, United States, Mexico | Seed, Debt Financing | Software, Information Technology, Health Care | $274k–$2.6M |
|
Clave Mayor
VC Fund
|
4 | Spain, Germany, United States | Seed, Series A | Software, Biotechnology, Medical | $262k–$8.9M |
|
Columbus Venture Partners
VC Fund
|
4 | Spain, United States, United Kingdom | Series B, Seed | Biotechnology, Health Care, Medical | $1.7M–$87M |
|
Amadeus Capital Partners
VC Fund
|
4 | United Kingdom, United States, Spain | Seed, Series B, Series A | Software, Artificial Intelligence, Information Technology | $900k–$43M |
|
Cofides
VC Fund
|
3 | Spain, Ecuador | Debt Financing, Private Equity, Series B | Manufacturing, Health Care, Industrial | $219k–$105M |
|
SOSV
VC Fund
|
3 | United States, India, United Kingdom | Seed, Convertible Note, Pre-Seed | Biotechnology, Health Care, Software | |
|
Fitalent
VC Fund
|
3 | Spain | Seed, Series A | Biotechnology, Analytics, Health Care | $165k–$4.8M |
|
European Investment Bank
VC Fund
|
3 | France, Germany, The Netherlands | Debt Financing, Post-IPO Debt | Biotechnology, Health Care, Energy | $16M–$658M |
|
ICF - Institut Català de Finances
VC Fund
|
3 | Spain, Germany | Debt Financing, Seed | Health Care, Medical, Biotechnology | $1.7M–$44M |
|
AVANTECA Partners
VC Fund
|
3 | Spain, Switzerland | Seed, Series A, Venture - Series Unknown | Biotechnology, Health Care, Security | $805k–$2.7M |
|
Startupxplore
VC Fund
|
3 | Spain | Pre-Seed, Seed, Convertible Note | Artificial Intelligence, Health Care, Software | $111k–$870k |
|
Faber
VC Fund
|
3 | Portugal, United States, United Kingdom | Seed, Pre-Seed, Series A | Artificial Intelligence, Software, SaaS | $34k–$25M |
|
WA4STEAM
VC Fund
|
3 | Spain | Seed, Pre-Seed, Series A | Health Care, Biotechnology, Artificial Intelligence | $392k–$4.2M |
|
Speedinvest
VC Fund
|
2 | United Kingdom, Germany, Austria | Seed, Series A, Pre-Seed | Software, FinTech, Financial Services | $549k–$33M |
|
Takeda Ventures
VC Fund
|
2 | United States, United Kingdom, Israel | Series A, Series B | Biotechnology, Health Care, Therapeutics | $10M–$130M |
|
Charme Capital Partners
VC Fund
|
2 | Spain | Series A | Genetics, Life Science, Biotechnology | $5.5M–$20M |
|
Santander
VC Fund
|
2 | United Kingdom, Spain, United States | Debt Financing, Post-IPO Debt, Seed | Energy, Renewable Energy, Financial Services | $100k–$1.5B |
|
Monte Carlo Capital
VC Fund
|
2 | United States, United Kingdom, Spain | Seed, Series A | Medical Device, Financial Services, Medical | |
|
BAGi
VC Fund
|
2 | Spain, Norway, Switzerland | Seed, Angel | Internet, Health Care, Software | $219k–$690k |
|
Kereon Partners
VC Fund
|
2 | Spain | Seed | Health Care, Cooking, Medical | $1.3M–$1.6M |
|
Josep Carreras Leukaemia Research Institute
VC Fund
|
2 | Spain | Seed | Life Science, Biotechnology | $3.4M–$7.3M |
|
Amino Collective
VC Fund
|
2 | United States, United Kingdom, Germany | Seed, Series A, Pre-Seed | Health Care, Biotechnology, Medical | $125k–$37M |
|
EASO Ventures
VC Fund
|
2 | Spain, Switzerland | Seed, Venture - Series Unknown | Software, Health Care, Manufacturing | $54k–$5.3M |
|
Blue Horizon Corporation
VC Fund
|
2 | United States, United Kingdom, Germany | Seed, Series A, Pre-Seed | Food and Beverage, Food Processing, Biotechnology | $450k–$28M |
|
Fondo Bolsa Social
VC Fund
|
2 | Spain, United States, United Kingdom | Seed, Grant, Series A | Artificial Intelligence, SaaS, Software | $212k–$19M |
| Access all 365 investors in Spain Biotechnology startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
The Center for Industrial Technological Development (CDTI) is a public corporation under the Ministry of Economy and Competitiveness, which promotes innovation and technological development of Spanish companies. Is the entity which channels requests for funding and support to projects I + D + i of Spanish companies in the national andinternational levels. The CDTI has a staff of more than 300 people formed three quarters of engineers and graduates. Although the bulk of the infrastructure of the CDTI is located in Madrid, the Centre offers Spanish companies a strategic network of offices and representatives abroad (Japan -SBTO (Spain Business and Technology Office) - Belgium -SOST (Spain Office of Science and Technology) and Permanent Secretariat Eureka-, Brazil -FINEP (Financier of Studies and Projects) -, Korea, Chile, Morocco, China, India, Mexico and USA) to support them in their technological activities of type int .
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Grant, Seed
- Geography: Spain, United States, France
Investor stats
- Total investments: 198
- Round size: Seed $562k–$5.9M; Grant $157k–$16M
- Lead/follow: 40% lead, 60% follow
Portfolio highlights
- Xoople — Xoople operates as an earth intelligence company. Xoople powers the next generation of Earth data intelligence to achieve a systematic understanding of physical changes on the Earth’s surface.
- Orga AI — Organ AI creates generative artificial intelligence that will help people. Its headquarters is located in Palma De Mallorca, Islas Baleares, Spain.
- Golden Owl —
Inveready is a leading Spanish financial services firm focused on investment solutions and wealth management.
Show more...Investment focus
- Industry: Software, Biotechnology, Information Technology
- Stage:Seed, Series A
- Geography: Spain, United States, United Kingdom
Investor stats
- Total investments: 176
- Round size: Seed $400k–$5.5M; Series A $1.6M–$14M
- Lead/follow: 48% lead, 52% follow
- Last fund: Likely actively investing — fund raised in 2024
Portfolio highlights
- Qrem —
- Shapelets — Shapelets optimizes GenAI and data visualization with advanced vector databases and agile tools for data professionals
- Wagmi Venture Studio — Wagmi VS is creating transformative web3 experiences that democratize opportunity and ownership of the internet.
Criteria Venture Tech is the tech VC fund of CriteriaCaixa which invests in B2B SaaS and DeepTech companies in early and growth stages (Seed to Series B) managing more than €300M of AUM.
Show more...Investment focus
- Industry: Software, Biotechnology, E-Commerce
- Stage:Seed, Series A
- Geography: Spain, United States, United Kingdom
Investor stats
- Total investments: 151
- Round size: Seed $256k–$3.8M; Series A $1.9M–$21M
- Lead/follow: 40% lead, 60% follow
- Last fund: Likely still investing — fund raised in 2021
Portfolio highlights
- Barbara — Barbara is the Cybersecure Industrial Edge Platform that enables companies to connect, deploy and scale gateways and edge applications in a few clicks
- Minoryx Therapeutics — Minoryx is focused on the discovery and development of novel treatments for severe, orphan diseases of the central nervous system with high unmet medical need.
- iPronics — iPronics develops the innovative concepts of general-purpose integrated programmable photonic systems.
Clave is an investment management company.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: Spain, Chile, Switzerland
Investor stats
- Total investments: 42
- Round size: Seed $462k–$5.5M; Series A $3.2M–$16M; Venture - Series Unknown $541k–$7.1M
- Lead/follow: 43% lead, 57% follow
- Last fund: Likely still investing — raised $53M in 2023
Portfolio highlights
- D-Sight — D-Sight is an early treatment for the leading cause of preventable blindness in the working-age population.
- Pharmacelera — Improving pharmaceutical R+D productivity through a lean drug discovery process based on advanced computational methodologies.
- BQC Redox Technologies — Assay kits and devices for rapid and easy quantification of REDOX parameters or biomarkers
SODENA is the main instrument of the Government of Navarre for the business development of the region. SODENA carries out its activities as a public limited company, with a majority direct shareholding of 65.42% by the Government of Navarre, and an indirect participation through Nafinco (14.58%). It also participates in the shareholding of GrupoCorporativo Empresarial Caja Navarra (20%), through TME 2001 CorpCan, S.L.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Manufacturing
- Stage:Debt Financing, Seed
- Geography: Spain, United Kingdom
Investor stats
- Total investments: 88
- Round size: Seed $110k–$922k; Debt Financing $37k–$743k
- Lead/follow: 31% lead, 69% follow
Portfolio highlights
- DARWIN Biomed — Biomedical Engineering
- Opportunity Health — Self-Applicable & Life-Saving | Fast, safe, and effective in emergencies | Contact us! | Opportunity Health
- El Caserío de Tafalla — El Caserío de Tafalla is a food production company that processes and supplies a variety of candies.
Invivo Capital is a team of knowledgeable professionals with the scientific, technical, and financial know-how required to analyze and make investments that provide value to the invested company. They also have a network of contacts and key strategic relationships in the health ecosystem.
Show more...Investment focus
- Industry: Biotechnology, Pharmaceutical, Health Care
- Stage:Seed, Series A
- Geography: Spain, France, Belgium
Investor stats
- Total investments: 26
- Round size: Seed $1.6M–$13M; Series A $2.2M–$70M
- Lead/follow: 35% lead, 65% follow
- Last fund: May invest from a new fund soon — raised $44M in 2019
Portfolio highlights
- ARTHEx Biotech — ARTHEx Biotech S.L. is a spin-off company of the University of Valencia that is developing advanced RNA treatments against genetic diseases.
- Gyala Therapeutics — Gyala Therapeutics is focused on developing new CAR-T therapies for treating hematological malignancies. CAR-T (chimeric antigen receptor T cells) is a type of gene therapy in which T lymphocytes -a type of white blood cells that play a key role in immune responses- are extracted from the patient and modified to attack tumour cells. T lymphocytesare obtained through apheresis (a technique that allows separation of blood components) and genetically reprogrammed with a receptor that binds to a tumor factor. When these cells are transduced back to the patient, they are to specifically recognize tumour cells and attack them. Several types of CAR-T cells have demonstrated efficacy in the treatment of leukemias and B cell lymphomas.
- Telomere Therapeutics — Telomere Therapeutics is a University of Barcelona spinoff developing telomerase gene therapy to treat pulmonary fibrosis
ENISA is a public company under the Ministry of Industry, Energy and Tourism, through the Directorate General of Industry and Small and medium-sized enterprises which, since 1982, actively participates in the financing of viable and innovative business projects.
Show more...Investment focus
- Industry: Software, Health Care, Artificial Intelligence
- Stage:Seed, Debt Financing, Pre-Seed
- Geography: Spain, United States, France
Investor stats
- Total investments: 219
- Round size: Seed $76k–$2.1M; Pre-Seed $188k–$1.2M; Debt Financing $66k–$549k
- Lead/follow: 43% lead, 57% follow
Portfolio highlights
- Naturr — Nature, which seeks to connect small-scale artisanal food producers from rural areas with urban consumers. Nature platform could serve as an important bridge for promoting local and sustainable food systems, benefiting both rural producers and urban consumers i
- Biotasmart —
- DARWIN Biomed — Biomedical Engineering
Asabys Partners is a venture capital firm that invests across the board in human healthcare. The company is active in the health-tech and biopharma industries and aims to invest in Spain and abroad in innovative and transformative technologies. Asabys Partners are motivated by the idea of pushing the boundaries of science and medicine. This is donethrough the sourcing and financing of the most disruptive technologies, and through the collaboration with the best internal and external talents of our industry.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Series A, Series B, Seed
- Geography: Spain, France, Belgium
Investor stats
- Total investments: 38
- Round size: Seed $1.2M–$13M; Series A $7M–$55M; Series B $18M–$135M
- Lead/follow: 50% lead, 50% follow
- Last fund: Likely still investing — raised $117M in 2022
Portfolio highlights
- Orikine Bio — Orikine Bio is a pioneer biotech company in the field of tailored cytokines with unmatched biological properties for the treatment of immune-mediated disorders.
- Splice Bio — Splice Bio is a gene therapy company based on technology developed in the Muir Lab at Princeton University. The company is developing novel gene therapies based on its proprietary intein platform technology to treat patients that suffer from incurable genetic diseases. The company’s platform has the potential to address two existing limitations ofadeno-associated viruses (AAVs), both by increasing the size of the cargo gene that can be delivered and by expanding the range of tissues that can be targeted.
- Ona Therapeutics — Ona Therapeutics is a biotech company that specializes in the discovery and development of therapeutic biologics targeting tumor metastatic-initiating cells and lipid metabolism. Founded in 2019 by Salvador Aznar-Benitah and Valerie Vanhooren, it was a spin-off from ICREA and Advanced Studies, and the IRB Institute for Research in Biomedicine.
BeAble Capital is a Science Equity Fund, therefore it is a pre-seed, seed and early stage venture capital management company specialized in the identification, valuation, launch and development of technologies in the sectors of advanced materials (nanotechnology and biotechnology), photonics, micro and nano electronics and Information andcommunications technologies (ICT) platforms.It acts as the link between scientific, entrepreneurial and investing worlds to promote the transfer of technology, the creation and the development of technology-based companies (start-ups) from private equity. The company is focused on strong intelectual property and long R&D background projects. Their work provide value at different stages of development by offering support in strategic points such as the identification of technologies, valuation, transfer, companies creation, fundraising, marketing, internationalization and administrative and managerial expertise.
Show more...Investment focus
- Industry: Biotechnology, Manufacturing, Software
- Stage:Pre-Seed, Seed
- Geography: Spain, Italy
Investor stats
- Total investments: 69
- Round size: Seed $154k–$1.2M; Pre-Seed $124k–$274k
- Lead/follow: 83% lead, 17% follow
- Last fund: May invest from a new fund soon — raised $37M in 2016
Portfolio highlights
- Molecular Gate — Molecular Gate refer to an innovative class of small-molecule drugs developed by Gate Bioscience. These drugs target the secretory translocon (Sec61 channel) in cells to selectively block and degrade harmful extracellular proteins before they can be secreted and cause disease.
- Bioinspired Materials — Bioinspired Materials is a Biotech-based entrepreneurship project with the participation of the Universitat Pompeu Fabra. The company develops wastewater valorization that produces biological products of high value in the market. BIOM was founded in 2019 and is based in Barcelona, Spain.
- Ars Magna Semiconductors — Ars Magna Semiconductors develops semiconductor chips designed for decentralized artificial intelligence applications. The company's technology operates with low energy consumption, real-time processing, and enhanced data privacy by reducing the number of operations and hardware requirements. Their chips address the global semiconductorshortage while enabling more efficient AI processing with reduced computational overhead.
Leading #lifesciences #venturecapital firm financing highly #innovative #biotechnology companies #worlwide.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: Spain, United States, Switzerland
Investor stats
- Total investments: 81
- Round size: Series A $3.8M–$61M; Series B $20M–$135M; Series C $27M–$80M
- Lead/follow: 30% lead, 70% follow
Portfolio highlights
- AM Pharma — AM-Pharma B.V., a biopharmaceutical company, engages in the development and commercialization of therapeutics for human use in the Netherlands. It focuses in the pre-clinical and clinical development of novel therapeutics to treat inflammatory and infectious diseases. The company develops products based on endogenous proteins and protein derivedpeptides, as well as molecules that naturally occur in the human body. Its products include alkaline phosphatase for treatment of acute kidney injury and ulcerative colitis; and immune response amplifying peptide hLF1-11 for the treatment of drug resistant hospital acquired infections. The company was founded in 2000 and is headquartered in Bunnik, the Netherlands.
- Splice Bio — Splice Bio is a gene therapy company based on technology developed in the Muir Lab at Princeton University. The company is developing novel gene therapies based on its proprietary intein platform technology to treat patients that suffer from incurable genetic diseases. The company’s platform has the potential to address two existing limitations ofadeno-associated viruses (AAVs), both by increasing the size of the cargo gene that can be delivered and by expanding the range of tissues that can be targeted.
- Synendos Therapeutics — Synendos Therapeutics is a biopharmaceutical company that aims to develop breakthrough safe and effective therapies for unmet needs in neuropsychiatric disorders through modulation of a new drug target in the endocannabinoid system that enables restoration of natural functioning of the brain.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!CDTI Innovación's INNVIERTE program is part of the Spanish Science, Technology, and Innovation Strategy. This Strategy is one of the cornerstones around which the Government's R&D&I strategy for the upcoming years is built. It outlines the goals, changes, and actions that must be implemented across the R&D&I sector inorder to maximize its growth and effect.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Venture - Series Unknown, Seed
- Geography: Spain, Panama, Switzerland
Investor stats
- Total investments: 50
- Round size: Seed $266k–$6.4M; Venture - Series Unknown $330k–$16M
- Lead/follow: 38% lead, 62% follow
Portfolio highlights
- MOA — MOA make healthy food for a sustainable world that solves growing global food demands. They are establishing a new industry of sustainable food that solves growing global food demands without the need for arable land. They are focused on designing high-value, natural and nutritious food.
- Zoundream — The Future of Infant Care
- Ona Therapeutics — Ona Therapeutics is a biotech company that specializes in the discovery and development of therapeutic biologics targeting tumor metastatic-initiating cells and lipid metabolism. Founded in 2019 by Salvador Aznar-Benitah and Valerie Vanhooren, it was a spin-off from ICREA and Advanced Studies, and the IRB Institute for Research in Biomedicine.
Capital Cell is a crowdinvesting platform for biotech and life sciences companies. Mixing VC, business angels, accredited investors, and the power of the crowd, the company is building a global meeting point for companies and researchers working, fostering, and financing tomorrow’s medical science.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Equity Crowdfunding, Seed
- Geography: Spain, France, United States
Investor stats
- Total investments: 51
- Round size: Seed $384k–$1.9M; Equity Crowdfunding $137k–$1.3M
- Lead/follow: 25% lead, 75% follow
Portfolio highlights
- DYNAMICS VR — Dynamics VR provides rehab software for clinics to tackle musculoskeletal pain and movement impairments caused by brain trauma.
- Axoltis Pharma — Axoltis Pharma is a biotech company that develops drugs for degenerative and traumatic neurological disorders.
- EVis Bioscience — EVis Bioscience offers gene delivery solutions using extracellular vesicles, lipid nanoparticles, and hybrid systems.
ICF Capital is a venture and growth capital management firm from ICF. ICF is a public financial institution founded in 1985 and owned by the Government of Catalonia. Our mission is to foster and improve access to funding for companies that operate in Catalonia in order to contribute to the growth of the region's economy while complementing theprivate financial sector. ICF provides funding to Catalan companies and entrepreneurs. They assist them in their development and growth, generating value for society at large. The institution offers companies a range of products and services in the area of corporate finance, focusing on loans and guarantees and venture capital investments. ICF operates via a parent company, two subsidiaries (IFEM and ICF Capital), and an investee (AVALIS). ICF, through IFEM, supports the creation and growth of innovative start-ups through the investment in venture capital funds for seed segments and co-investment with private investors through participative loans. ICF Capital, which manages closed-end UCITS and is authorized by Spain's National Securities Market Commission (CNMV), manages, nurtures, and advises public and/or private funds or venture capital firms that provide capital to Catalan companies. At present, ICF Capital directly manages 2 venture capital firms: ICF Capital Expansió II and ICF Venture Tech II.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Debt Financing, Seed
- Geography: Spain, United States, Mexico
Investor stats
- Total investments: 110
- Round size: Seed $1.1M–$6.9M; Debt Financing $110k–$549k
- Lead/follow: 20% lead, 80% follow
- Last fund: Likely actively investing — fund raised in 2024
Portfolio highlights
- Salicru — Salicru offers energy optimization and protection of technological equipment that causes incidences in the electrical supply.
- BRICKBRO — Currently, Brickbro is one of the leading real estate transactional platforms in the spanish market.
- ATTSU — ATTSU is a machinery manufacturing company that offers steam boilers and thermal oil boilers for industrial purposes.
Alta Life Sciences is a leading multistage venture capital investment firm. Alta LS will invest in companies at all stages of development: from seed financing through commercial growth. Alta LS invests in all areas of life sciences including biotechnology, medical devices, diagnostics, genomics and digital health.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical Device
- Stage:Series A, Series B
- Geography: Spain, United States
Investor stats
- Total investments: 18
- Round size: Series A $3M–$33M; Series B $14M–$87M
- Lead/follow: 44% lead, 56% follow
Portfolio highlights
- DeepUll — DeepUll is a biotech company that focuses its activity on the development of a new diagnostic system for early-stage sepsis condition. DeepUll’s proposal is based on quickly identifying the pathogens and offering the antibiogram within a few hours on the one hand, and on using the data and learning about the patient’s immunological and functionalstatus on the other. The system allows doctors to predict the future appearance and evolution of sepsis within a short period of time and thus provide a suitable clinical response even before the symptoms arise.
- Peptomyc — Peptomyc is a company focused on the development of a new generation of cell-penetrating peptides (CPPs) targeting the Myc oncoprotein for cancer treatment. The company was founded in December 2014 and it is based on Dr. Soucek’s scientific research in Omomyc (the best direct Myc inhibitor known to date) over the last twenty years.Currently,cancer incidence in the world exceeds 14 million cases per year and results in 8 million deaths annually. Moreover, such numbers are forecast to rise by 75% over the next 20 years (World Cancer Report. International Agency for Research on Cancer 2014). At the moment, standard therapies include surgery, radiotherapy, chemotherapy, and, in a restricted subset of cancers, precision medicine. Unfortunately, very often these therapies fail, due to the development of resistance.Peptomyc has adopted a different strategy based on the inhibition of the oncoprotein Myc, which is found deregulated in the majority of human cancers. Myc holds a non-redundant function in cancer around which tumors cannot evolve, hence targeting Myc is the most promising therapeutic opportunity to date. Although Myc plays a central role in cancer there is currently no Myc inhibitor in the market.
- Ona Therapeutics — Ona Therapeutics is a biotech company that specializes in the discovery and development of therapeutic biologics targeting tumor metastatic-initiating cells and lipid metabolism. Founded in 2019 by Salvador Aznar-Benitah and Valerie Vanhooren, it was a spin-off from ICREA and Advanced Studies, and the IRB Institute for Research in Biomedicine.
Independent Venture Capital Firm specialized in high technology Spanish start-ups. Helping tech entrepreneurs during the early stages of their company to build successful businesses
Show more...Investment focus
- Industry: Software, Information Technology, Manufacturing
- Stage:Seed, Series A
- Geography: Spain, United States, Mexico
Investor stats
- Total investments: 64
- Round size: Seed $1M–$3.3M; Series A $587k–$11M
- Lead/follow: 42% lead, 58% follow
- Last fund: Likely still investing — raised $47M in 2023
Portfolio highlights
- FlexiiC — FlexiiC is a deep-tech firm developing printed, flexible integrated circuits for sustainable IoT and smart packaging solutions.
- Bioherent — Photonic biosensors for drug allergy diagnosis
- Impetux Optics — IMPETUX develops and markets patented technology to characterise the mechanical properties of living tissues and cells. We are focusing the application of our technology in fields like Mechanobiology where the study of diseases directly related with cell migration or development are demanding new techniques. We offer cutting-edge non-invasive to...
XesGalicia is a Galician Venture Capital Management firm. It finances company development through the temporary acquisition of minority shares of the capital of unquoted companies.
Show more...Investment focus
- Industry: Software, Biotechnology, Pharmaceutical
- Stage:Seed, Pre-Seed
- Geography: Spain, Portugal
Investor stats
- Total investments: 33
- Round size: Seed $304k–$5.9M; Pre-Seed $439k–$2.5M
- Lead/follow: 15% lead, 85% follow
Portfolio highlights
- Kreios Space — Kreios Space is developing an electric propulsion system to revolutionize the satellite industry. With this technology we enable orbital keeping in VLEO (Very Low Earth Orbits) thanks to renewable energy. We make space applications easier.
- VigSec-Drone — VigSec-Drone is a high-performance security and surveillance designed to deliver real-time situational awareness.
- Iteria Biopharma — Iteria Biopharma focused on discovering and developing precision oncology drugs, particularly first-in-class new chemical entities (NCEs) for challenging cancer targets with high unmet medical needs.
CRB Inverbio is a private venture capital management firm specialized in life sciences investing in innovative early stage start- ups in biotech, med tech, digital health and medical technologies
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Series A, Seed
- Geography: Spain, Italy, Mexico
Investor stats
- Total investments: 14
- Round size: Seed $3.3M–$5.3M; Series A $2.2M–$8.9M
- Lead/follow: 36% lead, 64% follow
- Last fund: May invest from a new fund soon — raised $70M in 2010
Portfolio highlights
- Nuubo — Nuubo is a Spanish medical device company that develops wireless, wearable technologies to monitor physiological parameters. To do so, Nuubo has a platform known as nECG DYNAMIC PLATFORM, which makes it easier to perform and read an electrocardiogram remotely. Specifically, the system patented by Nuubo is made up of three elements: a biomedicalgarment that allows the electrocardiogram signal to be captured without interfering with the patient’s daily activity; a device that continuously records the information captured by the garment and which also allows the data to be sent wirelessly and in real time for processing; and analysis and visualization software that, using artificial intelligence algorithms, can interpret all of the information transmitted by the wireless device.The devices designed by Nuubo allow patients’ hearts to be monitored for longer periods of time and without feeling uncomfortable or intrusive. The company is headquartered in Madrid, Spain.
- Prosoma — Prosoma was born out a need to provide more comprehensive care for cancer patients. We have found a fundamental lack of access to psychological care for patients who not only have to face a life-altering disease and treatment, but also crucially have a different set of needs than other psychological patients. Barriers to accessing psychologicalcare often include low numbers of therapists and clinicians in the area, financial or geographical limitations, and the general wellbeing of patients preventing them from attending meetings. All of these issues can be solved by modern technology.By using VR as part of, or when necessary, an alternative to traditional psychological treatment, we can reach patients that would otherwise be left without any support. They can use our tool at home or in the clinics whilst undergoing pharmacological treatment and chemotherapy.We hope to provide patients with a tool that will help them manage stress, cope with the burden of cancer, and eventually improve their quality of life.
- Carol — Carol is a tech-enabled healthcare provider delivering membership-based primary care services, on a mission to make high-quality healthcare accessible and affordable for everyone. To achieve this goal, Carol leverages a highly scalable technology, combined with high quality clinical operations and a salaried provider model.
AdBio partners is a European Life Sciences Venture Capital firm dedicated to seeding healthcare’s step forward.We work with leading research institutions and well-established technology transfer offices, with a strong network of scientific and medical partners, exploring new territories to source breakthrough medical discoveries and driveinventive Life Sciences start-ups to success.We embrace European Life Sciences’ dynamic of innovation. Europe harbors a vibrant environment for medical and scientific investigation, with some of the most leading-edge academic and research centers. AdBio partners seizes the opportunity to highlight their undervalued research programs and assets and participate in structuring Europe’s biotechnology ecosystem.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Seed, Series A
- Geography: France, Spain, Belgium
Investor stats
- Total investments: 32
- Round size: Seed $2.2M–$18M; Series A $18M–$37M
- Lead/follow: 41% lead, 59% follow
- Last fund: Likely still investing — raised $116M in 2021
Portfolio highlights
- Orikine Bio — Orikine Bio is a pioneer biotech company in the field of tailored cytokines with unmatched biological properties for the treatment of immune-mediated disorders.
- ARTHEx Biotech — ARTHEx Biotech S.L. is a spin-off company of the University of Valencia that is developing advanced RNA treatments against genetic diseases.
- Integra Therapeutics — Integra Therapeutics is a developer of next generation of gene editing tools to cure diseases.
Venture Capital for Entrepreneurs with seasoned experts and advisors to succed in creating value in a meaningful way. Coaching and Mentoring Ideas People
Show more...Investment focus
- Industry: Health Care, Biotechnology, Artificial Intelligence
- Stage:Seed, Pre-Seed, Venture - Series Unknown
- Geography: Spain
Investor stats
- Total investments: 25
- Round size: Seed $549k–$9.5M; Pre-Seed $106k–$2.5M; Venture - Series Unknown $218k–$794k
- Lead/follow: 56% lead, 44% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- Tirecat — Tirecat specialized in developing sophisticated tissue regeneration treatments to combat chronic and terminal diseases.
- NSS Water —
- The Blue Box Biomedical Solutions — Pain-free, low-cost, sensitive, radiation-free device to detect breast cancer in urine
Gestión de Capital Riesgo del PaÃs Vasco SGECR, S.A. is a venture capital entity management company founded in 1985 by the Basque Government as part of the Sociedad para la Promoción y Reconversión Industrial (SPRI), with the aim of promoting and developing venture capital activity in the Basque Country.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Seed, Series A
- Geography: Spain, Ecuador
Investor stats
- Total investments: 23
- Round size: Seed $213k–$2.3M; Series A $329k–$14M
- Lead/follow: 35% lead, 65% follow
- Last fund: May invest from a new fund soon — last raise in 2014
Portfolio highlights
- InspectRail — InspectRail was established to offer high-quality information on the state of railway infrastructure, thereby enhancing its operation, management, and maintenance.
- Orbik Cybersecurity — Orbik Cybersecurity provides testing and compliance services for industrial equipment and embedded electronics.
- Inmedical Therapeutics — Innovative medical devices designed to meet real clinical needs, combining science, know-how and therapeutic research.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!A Banc Sabadell initiative to support young companies in developing their projects. Bstartup is designed to support entrepreneurs so their projects can be developed with maximum guarantees of success. - Investment and growth - Specialized products and branches - Collaborative innovation
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Pre-Seed
- Geography: Spain, Mexico, United States
Investor stats
- Total investments: 82
- Round size: Seed $110k–$2.2M; Pre-Seed $219k–$900k
- Lead/follow: 45% lead, 55% follow
Portfolio highlights
- TietAI — TietAI builds healthcare data interoperability infrastructure for hospitals, research networks and life sciences. The platform, Hydra, is split into two products. Hydra Connects is non-medical-device middleware for clinical data exchange across HL7v2, FHIR, DICOM, OMOP, X12 and CDA. Hydra Agentic is a high-risk AI system under the EU AI Act,designed for clinical agentic workflows.
- Energiot — Energiot specialized engineering service in energy harvesting, self-powered devices, wireless sensor networks.
- Floatech — Discover Floatech: Boosting lithium-ion batteries with sustainable, high-performance silicon anodes. Explore our innovative technology.
Moira Capital Partners is private equity firm
Show more...Investment focus
- Industry: Biotechnology, Apps, Water Purification
- Stage:Private Equity, Venture - Series Unknown
- Geography: Spain
Investor stats
- Total investments: 17
- Round size: Private Equity $7.9M–$18M; Venture - Series Unknown $5.5M–$15M
- Lead/follow: 82% lead, 18% follow
Portfolio highlights
- Cubiq Foods — Cubiq Foods has developed a platform of cultivate fats for industrial clients. It is based on two main ingredients, Cubiq Smart OMEGA-3 and Cubiq Smart Fat
- Xcalibur — Your Strategic Ally in Sustainable Energy Transition. Airborne Survey Solutions for Comprehensive Resource Mapping
- Geodesic Innovations — Geodesic Innovations is a water-saving and purification company that develops advanced water treatment, conservation, and regeneration systems to offer services for disinfection and improvement of water quality without using chemicals.
Seed Capital de Bizkaia is a Regional Council company affiliated to Biscay Regional Council's Department of Economic Development and Innovation (Departamento de Innovación y Promoción Económica de la Diputación Foral de Bizkaia) whose aim is to manage a Venture Capital Fund called “Seed Capital Bizkaia, F.C.R.“.
Show more...Investment focus
- Industry: Software, Biotechnology, Health Care
- Stage:Seed, Series A
- Geography: Spain, Mexico, Belgium
Investor stats
- Total investments: 34
- Round size: Seed $119k–$2.9M; Series A $2.7M–$14M
- Lead/follow: 26% lead, 74% follow
Portfolio highlights
- NNEAT — NNEAT operationalizes Continuous Threat Exposure Management (CTEM) and powers MITRE ATT&CK®-aligned Threat-Informed Defense (TID).
- Emica Solar — Emica Solar is a company which develops the floating solar energy.
- Revenant Industrial & Ports Machinery — Revenant returning to the revolution in internal logistics, container manipulators, and the remanufacturing of large tonelaje carretillas.
Angels Capital philosophy is to find and support at 1 able to lead a project. Their goal is to support the entrepreneurial, helping to create new businesses, help grow their business sector, generate employment and create wealth.
Show more...Investment focus
- Industry: Software, E-Commerce, Health Care
- Stage:Seed, Angel, Pre-Seed
- Geography: Spain, United States, Ireland
Investor stats
- Total investments: 127
- Round size: Seed $212k–$2.5M; Angel $104k–$1.6M; Pre-Seed $323k–$994k
- Lead/follow: 38% lead, 62% follow
Portfolio highlights
- Citring — Citring is a smart juicer to make orange juice automatically.
- Trak — Trak is a software tool for healthcare professional to provide AI-based tele-rehabilitation services like physiotherapy and others.
- Biotasmart —
As asset managers, we invest on behalf of third parties. Our fear of losing their money is greater than the fear of losing an opportunity. Our investment style consists of value orientation, specialization and trust, applying our investment criteria in a disciplined way. We invest to transform the companies into industry leaders. With a hands-onapproach, Nara invests in assets enhancing its value with a long-term view. We are a highly experienced team with the patience and tenacity required to see deals through, committing our own money. We create value in a sustainable way, investing in a responsible way to generate a positive impact on the community. We analyze each investment in detail in order to create shared value for our investors, partners, customers, suppliers and workers.
Show more...Investment focus
- Industry: Life Science, Biotechnology, Medical
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: Spain
Investor stats
- Total investments: 10
- Round size: Seed $394k–$7.3M; Venture - Series Unknown $1.9M–$3.3M
- Lead/follow: 30% lead, 70% follow
Portfolio highlights
- Aortyx — With a focus on aortic dissection, Aortyx has developed a bioresorbable endovascular patch designed to seal the entry tear, delivered through a proprietary dual-steerable catheter.
- MiMARK — MiMARK focuses on improving the accuracy and efficiency of diagnostics for endometrial cancer, which is the sixth most commonly occurring cancer in women.1 As with many cancers, early and accurate detection of the disease is linked to increased survival, however currently around a third of endometrial cancer patients are diagnosed at the advancedstage.2 By improving the technology available for the diagnosis of endometrial cancer, MiMARK hopes to improve the speed and accuracy at which women can be diagnosed and effectively treated.
- Neboda — We are an indoor vertical farming company that combines combines a scientific approach and an industrial automation background.
Developing combustion engine catalyst and coating technology to reduce emissions and improve fuel efficiency for clean energy production.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Debt Financing
- Geography: Spain, United States, Mexico
Investor stats
- Total investments: 34
- Round size: Seed $285k–$2.6M; Debt Financing $274k–$472k
- Lead/follow: 12% lead, 88% follow
Portfolio highlights
- PLD Space — PLD Space is a spanish innovative start-up company is to provide low cost and high reliability access to space. PLD Space offers suborbital and orbital launch services to its clients.
- SummuS Render — SummuS is a render farm, who offers 3D rendering and massive computing capabilites as a service. Companies demanding massive calculations for short periods of time can hire either the infraestructure or they can pay a price per Ghz per hour. This service allows them to avoid huge costs in hardware, personnel and system maintenance.
- Atlas Molecular Pharma — Latest News Your browser does not support the video tag.
Clave Mayor is a management company of closed investment entities based in Navarra.
Show more...Investment focus
- Industry: Software, Biotechnology, Medical
- Stage:Seed, Series A
- Geography: Spain, Germany, United States
Investor stats
- Total investments: 33
- Round size: Seed $262k–$5.5M; Series A $2.2M–$8.9M
- Lead/follow: 21% lead, 79% follow
Portfolio highlights
- MOA — MOA make healthy food for a sustainable world that solves growing global food demands. They are establishing a new industry of sustainable food that solves growing global food demands without the need for arable land. They are focused on designing high-value, natural and nutritious food.
- Ojer Pharma — Ojer Pharma engages in the research, development, production, and marketing of dermopharmaceutical products in Spain. It develops prescription medicines, cosmetics, and medical devices. The company has developed a vehiculization technology in the form of bioadhesive transparent gels, which acts as a sustained-release matrix of dermatologicalactives, such as lipophilics and hydrophilics.
- Semi Zabala — Welcome to Semi Zabala, a pioneering semiconductor company dedicated to innovation and excellence. Our mission is to push boundaries and enhance technology, embodying our slogan: beyond the power. Explore our advanced solutions designed for a smarter, more connected future.
Columbus Venture Partners is Spanish independent venture capital. It focuses on investing in early-stage opportunities in the life science industry. The firm is a team of investment professionals with a scientific, medical, and business development background combined with experience in building and investing in companies to accelerate theircommercialization.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Seed
- Geography: Spain, United States, United Kingdom
Investor stats
- Total investments: 26
- Round size: Seed $1.7M–$20M; Series B $26M–$87M
- Lead/follow: 58% lead, 42% follow
- Last fund: May invest from a new fund soon — raised $127M in 2021
Portfolio highlights
- Artax Biopharma — Discover Artax Biopharma's pioneering Nck modulators that restore immune balance without immunosuppression. Learn more about our clinical advancements.
- Ona Therapeutics — Ona Therapeutics is a biotech company that specializes in the discovery and development of therapeutic biologics targeting tumor metastatic-initiating cells and lipid metabolism. Founded in 2019 by Salvador Aznar-Benitah and Valerie Vanhooren, it was a spin-off from ICREA and Advanced Studies, and the IRB Institute for Research in Biomedicine.
- Integra Therapeutics — Integra Therapeutics is a developer of next generation of gene editing tools to cure diseases.
Amadeus Capital Partners, Venture Capital For Technology Companies. We Back Entreprenuers To Win. Contact Our Experienced Team Of Investors Today
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Series B, Series A
- Geography: United Kingdom, United States, Spain
Investor stats
- Total investments: 237
- Round size: Seed $900k–$9.2M; Series A $2.6M–$30M; Series B $6.8M–$43M
- Lead/follow: 29% lead, 71% follow
- Last fund: Likely still investing — raised $88M in 2023
Portfolio highlights
- Tenzo — Tenzo is a restaurant analytics and AI forecasting platform for restaurants, pubs and cafes. Tenzo makes running restaurants easy with full data visibility.
- Slamcore — Positioning, mapping and perception | State-of-the-art visual SLAM turns sensor data into actionable, spatial understanding for your vehicles.
- Unifyr — IDC MarketScape Leader 2025. AI-native PRM platform for partner onboarding, enablement, deal registration, and through-channel marketing.
Cofides provides cost-effective, medium and long-term financial support for viable private investment projects.
Show more...Investment focus
- Industry: Manufacturing, Health Care, Industrial
- Stage:Debt Financing, Private Equity, Series B
- Geography: Spain, Ecuador
Investor stats
- Total investments: 48
- Round size: Series B $42M–$87M; Debt Financing $219k–$24M; Private Equity $6.1M–$105M
- Lead/follow: 94% lead, 6% follow
Portfolio highlights
- Bike Ocasion — Bike Occasion offers certified bicycles, a one-year warranty, and home delivery of bikes. It also provides bicycle repair services. In addition to prioritizing sports and cycling, the firm strives to preserve the environment without compromising on its values.
- Thermogreen — Thermogreen manufactures and markets extruded polystyrene (XPS) for use in thermal insulation, which helps to sustainable and energy-efficient building while ensuring the well-being and comfort of its occupants.
- Fersa Bearings S.A. — Fersa Bearings is a Spanish multinational dedicated to the design, development, manufacture and distribution of complete solutions of high quality bearings for the automotive market. It has more than 50 years of experience in the sector and, since 2016, it forms part of the Fersa Group business group together with the Austrian manufacturer ofindustrial bearings, NKE.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Convertible Note, Pre-Seed
- Geography: United States, India, United Kingdom
Investor stats
- Total investments: 1482
- Lead/follow: no public data
Portfolio highlights
- MixRift — MIXRIFT - game developers specialized in Mixed Reality
- unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
- Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.
Fitalent (FIT Investment Talent SCR Simplified Regime SL) is a venture capital firm formed in early 2011 and registered in the special register of the National Securities Market Commission (CNMV), which invests in technology companies and proven successful products , whose main asset are people and talent .Their mission is to assistentrepreneurs to get consolidated, profitable and leading companies in the technology market segment. They want to be financial and strategic partners of the companies in which they participate.
Show more...Investment focus
- Industry: Biotechnology, Analytics, Health Care
- Stage:Seed, Series A
- Geography: Spain
Investor stats
- Total investments: 15
- Round size: Seed $165k–$2.6M; Series A $329k–$4.8M
- Lead/follow: 47% lead, 53% follow
Portfolio highlights
- Citibeats — Citibeats uses AI and cutting-edge technology to transform ethically sourced public opinions into real-time, data-driven actionable insights. Monitor trends surrounding sustainability, social risk, and more.
- Oncostellae — Oncostellae is a biotechnology startup developing small-molecule drugs with innovative scaffolds (NCEs) that modulate clinically validated therapeutic targets in oncology and inflammatory/autoimmune diseases.
- Ability Pharmaceuticals — Ability Pharmaceuticals is a drug discovery and development company based in Barcelona, Spain. It develops human therapeutics targeting cell membranes to treat cancer and other indications with unmet medical needs.Ability Pharmaceuticals is focused on developing new drugs for the treatment of lung cancer and pancreatic cancer. The companydevelops Lipid Analogue Therapeutics, a new drug class that modifies the composition of the cell membrane and displays a capacity to influence the local organization of lipid structures in the cell membrane, inducing the formation of non-lamellar phase structures.Its development pipeline includes ABTL0812 product in preclinical development; and ABTL1014, a drug candidate in preclinical characterization.
The European Investment Bank (EIB) offers lending, borrowing, and treasury services primarily within the European Union. It provides project loans for public and private sectors, loans to banks and intermediaries, structured finance products, guarantees, and securitization instruments for debts. Additionally, EIB offers equity and fund investmentproducts, including infrastructure and environmental funds, as well as venture capital funds. EIB also supports microfinance and risk-sharing finance for research and innovation, and provides technical expertise for sustainable energy projects. Its services include infrastructure advisory, urban development support, guarantees for transport infrastructure, and funding for public-private partnerships and small- to medium-sized enterprises. The bank serves various sectors, including transportation, energy, health, education, and agriculture.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Energy
- Stage:Debt Financing, Post-IPO Debt
- Geography: France, Germany, The Netherlands
Investor stats
- Total investments: 488
- Round size: Post-IPO Debt $16M–$658M; Debt Financing $16M–$370M
- Lead/follow: 82% lead, 18% follow
Portfolio highlights
- RE:OCEAN — OUR MISSION IS TO FARM SALMON FOR THE BENEFIT OF HEALTH AND THE PLANET. WE'LL DO THIS BY BUILDING A LARGE SCALE FISH FARM IN THE middle OF SWEDEN. - WE'RE MAKING THE IMPOSSIBLE POSSIBLE - AN OCEAN ON LAND. RE:OCEAN IN BRIEF One in five salmons in Sweden 2026 will come from RE:OCEAN Fresh
- Wandercraft — Self- balancing and hands free movement with the innovative self-balancing feature, Atalante allows for multi-tasking and cognitive involvement as part of treatments.
- IPT PowerTech — IPT PowerTech coverage, coupled with our extensive expertise in supply chain management, field implementation, and power systems, has made us one of the most capable companies in handling the most complicated and versatile projects in the MEA region and its neighboring countries.
ICF - Institut Català de Finances provides financial services.
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Debt Financing, Seed
- Geography: Spain, Germany
Investor stats
- Total investments: 13
- Round size: Seed $2.4M–$2.9M; Debt Financing $1.7M–$44M
- Lead/follow: 69% lead, 31% follow
Portfolio highlights
- D-Sight — D-Sight is an early treatment for the leading cause of preventable blindness in the working-age population.
- Super's Diana — Super’s Diana develops, manufactures, and markets medicines and supplements for swine, cattle, and poultry livestock in over 30 countries.
- Labiana Life Sciences — LABIANA GROUP has unique operational flexibility and a great capacity to offer high quality contract manufacturing services to all companies in the sector, regardless of batch size required.
A privately held asset management company that invests in early-stage life science companies.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Security
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: Spain, Switzerland
Investor stats
- Total investments: 6
- Round size: Seed $805k–$2.7M
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- Bearmind — Bearmind developing technology for monitoring and real-time analysis of head impact in athletes.
- Nanoligent — Explore how Nanoligent uses cutting-edge technology to design precision medicines, enhancing treatment efficacy and patient outcomes.
- Onena Medicines — Onena Medicines is a biotechnology company that creates innovative biological medicines to address the large unmet clinical need for breast cancer and other serious orphan illness.
Startupxplore is a premium startup investment platform that allows unexperienced and time-savvy investors to diversify their portfolio by co-investing with a group of top-level investors with a proven track record on startup investment.
Show more...Investment focus
- Industry: Artificial Intelligence, Health Care, Software
- Stage:Pre-Seed, Seed, Convertible Note
- Geography: Spain
Investor stats
- Total investments: 28
- Round size: Seed $276k–$870k; Pre-Seed $111k–$612k
- Lead/follow: 36% lead, 64% follow
Portfolio highlights
- Heuristik — Heuristik is a software solution that helps healthcare entities identify and manage patients by combining fingerprint recognition and artificial intelligence. They help with process planning and the administrative management of patients through the use of statistical analysis and proprietary management algorithms.
- Biel Glasses — Biel Glasses is a company from Barcelona developing smart glasses to improve the quality of life of people with low vision.
- Opportunity Health — Self-Applicable & Life-Saving | Fast, safe, and effective in emergencies | Contact us! | Opportunity Health
Faber is a Lisbon-based venture capital firm investing in outstanding entrepreneurs who innovate at the intersection of science and technology to drive digital transformation and climate action. The firm combines a specialist focus on deep tech early-stage startups with dedicated funds, investment teams and expert advisors to actively helpfounders build global companies powered by AI/Data, Web3 or Ocean/Climate technologies.Faber’s unique approach in Southern Europe is led by an entrepreneurial management partnership and backed by notable thesis-driven institutions and private investors. Investing since 2013, the firm has been an early investor in hard tech companies such as Unbabel, SWORD Health, Codacy, iLoF or YData.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, SaaS
- Stage:Seed, Pre-Seed, Series A
- Geography: Portugal, United States, United Kingdom
Investor stats
- Total investments: 91
- Round size: Seed $549k–$5.2M; Pre-Seed $34k–$3.8M; Series A $2.5M–$25M
- Lead/follow: 27% lead, 73% follow
- Last fund: Likely actively investing — fund raised in 2024
Portfolio highlights
- Vyoma GmbH — Vyoma ensures satellite safety and real-time mapping of space objects with cameras on satellites paired with automation services.
- Apres — Apres is a distributed learning engine built to enable high-performance, user-friendly AI for the world.
- ATMOS Space Cargo — ATMOS Space Cargo develops and manufactures space capsules to return cargo from space, microgravity experiments, Commercial products to entire rocket stages.
WA4STEAM is an all women angels investment group delivering worldwide access to seed capital for women entrepreneurs led startups in STEAM Science, Technology, Engineering , Architecture & Architecture and Mathematics
Show more...Investment focus
- Industry: Health Care, Biotechnology, Artificial Intelligence
- Stage:Seed, Pre-Seed, Series A
- Geography: Spain
Investor stats
- Total investments: 21
- Round size: Seed $392k–$4.2M; Pre-Seed $713k–$1.2M
- Lead/follow: 24% lead, 76% follow
Portfolio highlights
- Break-Event — Break-Event aids music industry professionals and businesses by transforming information into knowledge. They are dedicated to providing the product, enabling customers to make wiser decisions, and ensuring the performance of events.
- Hair Up Laser — Making alopecia a problem of the past.
- Genbioma — Genbioma is a biotechnology company transforming microbiome science into clinically validated postbiotics that support metabolic health, improve glucose control, and naturally activate the GLP-1 pathway.
Speedinvest is a globally active European venture capital firm built on a simple belief: many move more. From six offices across EMEA, our sector-focused investment teams back relentless founders from pre–Seed to Growth with long-term conviction, providing day-one access to our global network of corporate customers, experts, industry leaders, andtop-tier follow-on investors to scale smarter and faster. Building lasting companies like Bitpanda (Austria), Moove (Nigeria), Gigs (U.S.), Tide (UK), ARX Robotics (Germany), Wayflyer (Ireland), GoStudent (Austria), Seqera Labs (Spain), and Cylib (Germany) — together. Big ideas may start with one. But scaling and winning take The Power of More.
Show more...Investment focus
- Industry: Software, FinTech, Financial Services
- Stage:Seed, Series A, Pre-Seed
- Geography: United Kingdom, Germany, Austria
Investor stats
- Total investments: 552
- Round size: Seed $980k–$8M; Pre-Seed $549k–$4.1M; Series A $4M–$33M
- Lead/follow: 42% lead, 58% follow
- Last fund: Likely still investing — raised $384M in 2022
Portfolio highlights
- Bikemap — Bikemap is the crowdsourced cycling map & navigation of the world. With the help of more than 2.3M users in 100 countries, Bikemap helps you find the best cycling route from A to B - every time. Users shared more than 4M cycling routes in all corners of the world - and within the Bikemap Premium subscription, tens of thousands get access tooffline, routing, map features.
- morgana — Morgana is reshaping the mortgage industry in Latam. With a 5x faster application process, in-depth market knowledge, privileged access to data, and superb team, we are a groundbreaking digital mortgage broker that will shortly be competing with banks.
- GAMINSIDE — GAMINSIDE revolutionizes your relationship with your customers. As European full service provider, we deliver the complete package with solutions, services and software for gamified loyalty that is tailor-made and unique to your products, brands and customers. Integrate the best ideas from gamification and customer loyalty in your business areato exceed your commercial targets with GAMINSIDE.
Takeda Ventures, Inc. (TVI) is the corporate investment arm of Takeda Pharmaceutical Company Limited (TPC). TVI was founded in 2001 and invests in current and future areas of interest for TPC. They are based alongside Takeda’s R&D sites in Cambridge, MA, and San Diego, CA. As a strategic investor, TVI aims to provide support and guidance toentrepreneurs and early-stage companies driving concepts through clinical proof of concept. They also strive to forge active, collaborative interactions that result in synergies with Takeda's considerable R&D resources. Their goal is to build a portfolio of strategic investments, with an immediate emphasis on oncology, gastroenterology, neuroscience, and rare diseases.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B
- Geography: United States, United Kingdom, Israel
Investor stats
- Total investments: 104
- Round size: Series A $10M–$58M; Series B $20M–$130M
- Lead/follow: 18% lead, 82% follow
Portfolio highlights
- Integra Therapeutics — Integra Therapeutics is a developer of next generation of gene editing tools to cure diseases.
- Accipiter Biosciences — Accipiter Biosciences is a biotechnology company.
- Harness Therapeutics — Transine Therapeutics is a private biotechnology company focused on the development of a novel class of therapeutic RNAs that can upregulate protein expression with an unprecedented level of control and specificity: the SINEUPs®. The company's pioneering technology is expected to offer an entirely unique mechanism of action for currentlyhard-to-treat diseases by massively extending the druggable proteome and allowing it to address diseases that have been beyond the reach of small molecules, conventional biologics, or gene therapies.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Charme Capital Partners is a European mid-market private equity fund, supporting management teams and shareholders to achieve transformational change, growth and internationalisationFrom our offices in Milan, London and Madrid we invest in businesses across Europe with an enterprise value of €100m to €500mContinuous interaction with ourinvestor base is key in sourcing new opportunities, testing investment theses and growing portfolio companies
Show more...Investment focus
- Industry: Genetics, Life Science, Biotechnology
- Stage:Series A
- Geography: Spain
Investor stats
- Total investments: 3
- Round size: Series A $5.5M–$20M
- Lead/follow: 67% lead, 33% follow
Portfolio highlights
- Bianalisi — Bianalisi provides services that include toxicological examination of the hair, diagnostic imaging, specialised examinations, laboratory analysis, physiotherapy and rehabilitation, occupational medicine, and more. They offer diagnostic services.
- Veritas Intercontinental — Our test based on whole exome and genome sequencing provides the interpretation of extensive genetic information that can be further analyzed in the future.
Our purpose is to help people and businesses prosper. We strive to make all we do Simple, Personal and Fair.
Show more...Investment focus
- Industry: Energy, Renewable Energy, Financial Services
- Stage:Debt Financing, Post-IPO Debt, Seed
- Geography: United Kingdom, Spain, United States
Investor stats
- Total investments: 124
- Round size: Seed $100k–$3.3M; Post-IPO Debt $14M–$1.5B; Debt Financing $16M–$1.5B
- Lead/follow: 31% lead, 69% follow
- Last fund: May invest from a new fund soon — raised $658M in 2019
Portfolio highlights
- Ebury — Ebury UK | The Latest Fintech & Finance Solutions
- InstaVolt — InstaVolt is leading the way in EV charging infrastructure, helping to make the UK an easier place to own and operate an electric vehicle.They own, install and maintain rapid electric vehicle charging units all over the country, giving landowners the opportunity to earn a rental income by housing them, and giving EV drivers access to the fastestcharging available.They are driven by their passion for protecting the environment. At their core is a mission to improve air quality and reduce carbon emissions.Air quality has reached critical levels in cities across the UK and cars, buses and lorries have been proven as contributing significantly to the problem. Increasing the use of electric vehicles, which emit zero emissions, is an important part of the solution.According to Government statistics, one of the biggest barriers that deters people from buying EVs is range anxiety – the fear of running out of charge. InstaVolt will ensure a rapid charging point is easily accessible to everyone in the country.They believe that charging an electric vehicle should be quick and easy. It’s why, unlike many other companies, they operate an ‘open charger’ model, so anyone can use their charging points on a pay-as-you-go basis. No monthly subscription and no membership cards are required.
- GreenYellow — Green Yellow Holding generates electricity from centralized power plants and offers solar panels. The company allows anyone to produce and manage energy while creating value, through solar photovoltaics, efficiency, and energy optimization. The company was founded in 2007 and is headquartered in France.
Discover Monte Carlo Capital, a leading angel investment firm supporting early-stage startups in technology.
Show more...Investment focus
- Industry: Medical Device, Financial Services, Medical
- Stage:Seed, Series A
- Geography: United States, United Kingdom, Spain
Investor stats
- Total investments: 51
- Lead/follow: no public data
Portfolio highlights
- 1849 Bio — 1849 Bio creates microbes for affordable metal extraction from low-grade copper and gold ores.
- Scout AI — Scout AI is building the robotic foundation model for defense.
- Borderless AI — Borderless AI is an Employer of Record (EOR) & PEO platform simplifying global payroll management & team hiring to empower your growth worldwide. Book a demo now!
BAGi is the first business angels network created for invest on Startups with direct impact on Girona's region.
Show more...Investment focus
- Industry: Internet, Health Care, Software
- Stage:Seed, Angel
- Geography: Spain, Norway, Switzerland
Investor stats
- Total investments: 8
- Round size: Seed $219k–$690k
- Lead/follow: 38% lead, 62% follow
Portfolio highlights
- Aniling — Aniling developing its worldwide patent of the second generation genomic analysis and epigenomic.
- Petoons Studio — Petoons Studio is a developer of transmedia projects startup.
- The Smart Lollipop — The Smart Lollipop is a non-intrusive medical device in the shape of a lollipop with the goal to detect diseases with a single saliva sample.
> smart projects
Show more...Investment focus
- Industry: Health Care, Cooking, Medical
- Stage:Seed
- Geography: Spain
Investor stats
- Total investments: 4
- Round size: Seed $1.3M–$1.6M
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- Qualityfry — If you are looking for an automatic commercial deep fryer for your business, check the QualityFry ones. Check out and request a demonstration
- Persei vivarium (Digital Health) — Persei vivarium is a digital health business dedicated to the creation of high-quality data collections that are based on real-word data for specific diseases. The technology facilitates the capture of clinical data from the physician’s daily clinicalpractice and from the patient based on a mobile appication for remote monitoring. This provides a more holistic view and better management of the disease. The information that is captured becomes a high-value resource that also, in a simple and easy process, generates high-quality research.
- Transplant Biomedicals — Diabetes can be effectively controlled by following these best tips from Diabetes Guide. You will also get to know about the tips to manage diabetes naturally
International research Institute that pursues to study and eradicate Leukaemia, Lymphoma and other Hemopathies.
Show more...Investment focus
- Industry: Life Science, Biotechnology
- Stage:Seed
- Geography: Spain
Investor stats
- Total investments: 2
- Round size: Seed $3.4M–$7.3M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- OneChain Immunotherapeutics — CAR-T Immunotherapies against hematological malignancies
Amino Collective is an institutional venture capital firm investing at seed stage in health and bio companies. They help bring life-changing ideas to life by backing, connecting, and advancing our collective of entrepreneurs and scientists. The firm intends to invest in the sectors of biology, biotech, health tech, science, digital health, lifescience, and synthetic biology.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, United Kingdom, Germany
Investor stats
- Total investments: 44
- Round size: Seed $2.4M–$15M; Pre-Seed $125k–$7.8M; Series A $12M–$37M
- Lead/follow: 5% lead, 95% follow
Portfolio highlights
- Anima — Anima's online patient triage speeds up the clinical workflow 10x and allows providers to deliver the right care for patients within 24 hours.Millions of patients with serious problems are missed and die every year because there isn’t adequate information flow between medical appointments. Patients submit their problems and requests onAnimainstead of waiting for an appointment, and Anima sends an actionable report to their provider with trends, risks and recommendations.
- Aware — Aware is a mobile app for evaluating health data and for researching chronic diseases.
- Nostos Genomics — Our genetic variant interpretation platform enables genetic testing labs to give more people with genetic diseases a clear and fast diagnosis.
Easo Ventures es una Sociedad de Capital Riesgo Vasca y Privada, cuyo objetivo es invertir en Startups y PYMES con proyectos de crecimiento.
Show more...Investment focus
- Industry: Software, Health Care, Manufacturing
- Stage:Seed, Venture - Series Unknown
- Geography: Spain, Switzerland
Investor stats
- Total investments: 76
- Round size: Seed $266k–$3.2M; Venture - Series Unknown $54k–$5.3M
- Lead/follow: 26% lead, 74% follow
Portfolio highlights
- Energiot — Energiot specialized engineering service in energy harvesting, self-powered devices, wireless sensor networks.
- DYNAMICS VR — Dynamics VR provides rehab software for clinics to tackle musculoskeletal pain and movement impairments caused by brain trauma.
- DARWIN Biomed — Biomedical Engineering
Blue Horizon is accelerating the transition to a sustainable food system that delivers outstanding returns for the planet and people.
Show more...Investment focus
- Industry: Food and Beverage, Food Processing, Biotechnology
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, United Kingdom, Germany
Investor stats
- Total investments: 94
- Round size: Seed $2M–$12M; Pre-Seed $450k–$6.3M; Series A $2M–$28M
- Lead/follow: 32% lead, 68% follow
- Last fund: May invest from a new fund soon — raised $187M in 2021
Portfolio highlights
- WOW EARN — Discover WOW EARN, the all-in-one Web3 app with crypto mining, multi-chain wallet, staking NFTs, and marketplace dApps. Join the global Web3 community today.
- EV Biotech — We design and optimise your precision fermentation strains and processes, tailored to your success.
- foodforecast — AI supported solution to reduce food waste.
Fondo Bolsa Social venture capital fund that invests into startups or new companies that generates positive social and environmental impact.
Show more...Investment focus
- Industry: Artificial Intelligence, SaaS, Software
- Stage:Seed, Grant, Series A
- Geography: Spain, United States, United Kingdom
Investor stats
- Total investments: 29
- Round size: Seed $212k–$2.7M; Series A $5.4M–$19M
- Lead/follow: 76% lead, 24% follow
Portfolio highlights
- Innogando — Innogando focused on digital and technological solutions for livestock farming, particularly through GPS monitoring, traceability, and animal welfare systems.
- Turicleta — Turicleta is a service that offers electric bike rentals, allowing people to explore and enjoy nature in an eco-friendly way! Renting electric bikes can be a great way to experience the outdoors without exerting too much effort, especially on longer rides or hilly terrain.
- Punto Health — AI-Powered, Personalised Support for Every Patient and Family
Biotechnology Investor funding in Spain at a glance
Stats across 459 deals from 365 investors.
Access all 365 investors in Spain Biotechnology startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Biotechnology Investors in Spain investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 365 investors investing in Spain Biotechnology startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!